PapilloDia

Indicaton

PapilloDia is an innovative rapid test for the detection of cervical pre-cancer and cancer in 15 minutes.

Therapeutic indications

Type of product

Diagnostic

Table

Phase

Marketed
Partnering status

Not partnered
Available in

EU, Switzerland

You may also be interested in

Proclarix

Proclarix® is CE marked, intended for in vitro diagnostic use and indicated for prostate cancer diagnosis in patients with normal digital rectal exam (DRE), enlarged prostate volume and elevated levels of PSA at 2-10 ng/ml.

Marketed

C-PTBE-01

C-PTBE-01 has shown a strong steroid-sparing effect in two clinical safety and efficacy studies in patients with brain tumors and peritumoral brain edema (PTBE). C-PTBE-01 can lead to a market reduction or complete replacement of steroid use. This can alleviate the severe steroid-induced side effects and thus improve the quality of life of those affected.

Phase II completed

small molecule therapeutic that aims to treat Alzheimer’s patients

Alzheimer’s disease

Discovery